Laboratory Corporation of America Holdings (LH)

NYSE: LH · IEX Real-Time Price · USD
205.73
-0.77 (-0.37%)
Apr 12, 2024, 4:00 PM EDT - Market closed
-0.37%
Market Cap 17.30B
Revenue (ttm) 12.16B
Net Income (ttm) 418.00M
Shares Out 84.10M
EPS (ttm) 4.77
PE Ratio 43.13
Forward PE 13.48
Dividend $2.88 (1.40%)
Ex-Dividend Date May 28, 2024
Volume 692,245
Open 205.21
Previous Close 206.50
Day's Range 204.40 - 206.40
52-Week Range 179.59 - 234.09
Beta 1.00
Analysts Buy
Price Target 243.42 (+18.32%)
Earnings Date Apr 25, 2024

About LH

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepa... [Read more]

Sector Healthcare
Founded 1971
Employees 67,000
Stock Exchange NYSE
Ticker Symbol LH
Full Company Profile

Financial Performance

In 2023, LH's revenue was $12.16 billion, an increase of 2.51% compared to the previous year's $11.86 billion. Earnings were $418.00 million, a decrease of -67.32%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for LH stock is "Buy." The 12-month stock price forecast is $243.42, which is an increase of 18.32% from the latest price.

Price Target
$243.42
(18.32% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , April 11, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a ca...

2 days ago - PRNewsWire

Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit

The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment BURLINGTON, N.C. , April 10, 2024 /PRNewswire/ -- Lab...

3 days ago - PRNewsWire

Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs

Portfolio expansion solidifies company's commitment to advancing cancer research and patient care BURLINGTON, N.C. , April 8, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and...

5 days ago - PRNewsWire

Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research

Labcorp Plasma Detect is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer BURLINGTON, N.C. , April 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global...

8 days ago - PRNewsWire

Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research

Researchers to present on topics ranging from molecular residual disease and immunotherapy to whole-genome sequencing BURLINGTON, N.C. , April 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global lead...

11 days ago - PRNewsWire

Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp

SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has added new elements to its research c...

12 days ago - Business Wire

The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab

Expanded partnership to help increase patient access to critical genetic screening services including genetic counseling and test result turnaround time  HOUSTON , March 29, 2024 /PRNewswire/ -- The P...

15 days ago - PRNewsWire

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Transaction to enhance Labcorp's laboratory services network  and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI , March 28, 2024 /PRNewswire/ -- L...

Other symbols: OPK
16 days ago - PRNewsWire

Labcorp to Announce First Quarter Financial Results on April 25, 2024

BURLINGTON, N.C. , March 27, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2...

17 days ago - PRNewsWire

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials

Addition of pTau217 test further expands the company's leadership in testing options for Alzheimer's disease to improve patient care  BURLINGTON, N.C. , March 20, 2024 /PRNewswire/ -- Labcorp (NYSE: L...

24 days ago - PRNewsWire

Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer

Outcomes point to value of biomarker testing in addressing testing gaps in clinical practice BURLINGTON, N.C. , March 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and com...

4 weeks ago - PRNewsWire

Labcorp Launches Weight Loss Management Testing Solutions

New offering to support individuals and physicians with accessible and convenient testing options to guide weight loss management decisions and treatments BURLINGTON, N.C. , March 7, 2024 /PRNewswire/...

5 weeks ago - PRNewsWire

Labcorp forecasts 2024 profit above estimates on strong testing demand

Laboratory Corporation of America on Thursday forecast 2024 profit above Wall Street expectations and beat fourth-quarter profit estimates, as resilient demand for routine test kits boosted sales in i...

2 months ago - Reuters

Labcorp Announces 2023 Fourth Quarter and Full Year Results

Company Provides 2024 Guidance Results from Continuing Operations for the fourth quarter and full year versus last year: Revenue: Q4 of $3.03 billion vs $2.93 billion; Full year of $12.16 billion vs $...

2 months ago - PRNewsWire

Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine

BURLINGTON, N.C. , Feb. 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine's list of the Wo...

2 months ago - PRNewsWire

Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women

B•R•A•H•M•S™ sFlt-1/PlGF KRYPTOR™ Test System is available through physicians and is the first FDA-cleared biomarker test to aid in the risk assessment of progression to preeclampsia with severe featu...

2 months ago - PRNewsWire

Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

BURLINGTON, N.C. , Jan. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter and ...

3 months ago - PRNewsWire

Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities

Collaboration Aims to Improve Patient Experience, Accessibility and Efficiency in Decentralized Clinical Trials BURLINGTON, N.C. and LAFAYETTE, Calif.

3 months ago - PRNewsWire

Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. , Jan. 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team w...

3 months ago - PRNewsWire

Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives

NEW YORK--(BUSINESS WIRE)--Madryn Asset Management, LP (collectively with its affiliates, “Madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of SomaLogic, Inc. (“SomaLog...

3 months ago - Business Wire

Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship

Agreement Expands Access to Labcorp's Diagnostics Capabilities and Services BURLINGTON, N.C. , Nov. 20, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laborat...

5 months ago - PRNewsWire

Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments

BURLINGTON, N.C. and WASHINGTON , Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation  (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp, a global leader of inn...

5 months ago - PRNewsWire

Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy and Labcorp's multi-year agreement will increase access to Geneoscopy's next-generation colorectal cancer screening test.

5 months ago - Business Wire

Ovia Health Unveils New Fertility and Family Building Benefit

Expanded offering adds inclusive end-to end support for pre-conception, adoption and surrogacy while removing barriers to equitable care access BOSTON , Nov. 8, 2023 /PRNewswire/ -- Ovia Health by Lab...

5 months ago - PRNewsWire

Labcorp beats quarterly profit estimates on strength in routine testing segment

Laboratory Corporation of America topped Wall Street expectations for quarterly adjusted profit on Thursday, as strength in its routine diagnostics business more than offset weak COVID test sales.

6 months ago - Reuters